Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
Cardiovasc Diabetol
; 19(1): 14, 2020 02 08.
Article
in En
| MEDLINE
| ID: mdl-32035487
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protease Inhibitors
/
Triglycerides
/
Diabetes Mellitus, Type 2
/
Dyslipidemias
/
Antibodies, Monoclonal, Humanized
/
PCSK9 Inhibitors
/
Cholesterol, HDL
/
Anticholesteremic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cardiovasc Diabetol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
ENDOCRINOLOGIA
Year:
2020
Document type:
Article
Country of publication:
Reino Unido